NearWave Optical Molecular Monitoring

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT06744465
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • NearWave monitoring — DEVICE
    NearWave optical molecular monitoring

Study Details

The purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy (NAC).

Key Dates

First listed
Dec 20, 2024
Start date
Mar 7, 2025
Status verified
Feb 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: NearWave monitoring
    Breast cancer patients receiving neoadjuvant chemotherapy treatment followed by surgery will be monitored by a noninvasive handheld imaging device before, during and after chemotherapy.

Primary Outcome Measure

Feasibility of using NearWave imaging as a monitoring system [ Time Frame: Over approximately 5 months; baseline, mid way through treatment, and at last dose of clinical chemotherapy/prior to clinical surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University Simon Comprehensive Cancer CenterIndianapolisIndiana46202
Tarah J Ballinger, MD
[email protected]
3172742556
Xin Bryan, RN
[email protected]
317-312-2793
Tarah J Ballinger, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Indianapolis, IN

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Indiana University Simon Comprehensive Cancer Center· Indianapolis, IN

Related Studies